中华皮肤科杂志 ›› 2018, Vol. 51 ›› Issue (9): 707-709.doi: 10.3760/cma.j.issn.0412-4030.2018.09.024
温禾1,姚煦2
收稿日期:2017-08-10
修回日期:2017-10-02
出版日期:2018-09-15
发布日期:2018-08-30
通讯作者:
姚煦
E-mail:dryao_xu@126.com
He WEN1,
Received:2017-08-10
Revised:2017-10-02
Online:2018-09-15
Published:2018-08-30
摘要： 皮肤表面稳定的微生物群组是维持人皮肤健康和良好状态的一个重要因素［1］。皮肤微生物参与了特应性皮炎（AD）的发生发展，靶向和纠正皮肤微生物群的异常以恢复皮肤表面微生物的稳态是AD预防和治疗的新手段……
温禾 姚煦. 外用益生菌在防治特应性皮炎中的应用[J]. 中华皮肤科杂志, 2018, 51(9): 707-709.
He WEN. Topical application of probiotics in the prevention and treatment of atopic dermatitis[J]. Chinese Journal of Dermatology, 2018, 51(9): 707-709.
| ［1］ | Salinas T, Piquette⁃Miller M. Within our skin［J］. Clin Pharmacol Ther, 2017,102（1）:8⁃12. doi: 10.1002/cpt.708.<br /> |
| ［2］ | Scharschmidt TC, Fischbach MA. What lives on our skin: ecology, genomics and therapeutic opportunities of the skin microbiome［J］. Drug Discov Today Dis Mech, 2013,10（3⁃4）: e83⁃e89. doi: 10.1016/j.ddmec.2012.12.003.<br /> |
| ［3］ | Grice EA, Segre JA. The skin microbiome［J］. Nat Rev Microbiol, 2011,9（4）:244⁃253. doi: 10.1038/nrmicro2537.<br /> |
| ［4］ | Kong HH, Oh J, Deming C, et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis［J］. Genome Res, 2012,22（5）:850⁃859. doi: 10.1101/gr.131029.111.<br /> |
| ［5］ | Shi B, Bangayan NJ, Curd E, et al. The skin microbiome is different in pediatric versus adult atopic dermatitis［J］. J Allergy Clin Immunol, 2016,138（4）:1233⁃1236. doi: 10.1016/j.jaci.2016. 04.053.<br /> |
| ［6］ | Oh J, Freeman AF; NISC Comparative Sequencing Program, et al. The altered landscape of the human skin microbiome in patients with primary immunodeficiencies［J］. Genome Res, 2013,23（12）:2103⁃2114. doi: 10.1101/gr.159467.113.<br /> |
| ［7］ | Gonzalez ME, Schaffer JV, Orlow SJ, et al. Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis［J］. J Am Acad Dermatol, 2016,75（3）:481⁃493. doi: 10.1016/j.jaad.2016.04.066.<br /> |
| ［8］ | Zhang E, Tanaka T, Tajima M, et al. Characterization of the skin fungal microbiota in patients with atopic dermatitis and in healthy subjects［J］. Microbiol Immunol, 2011,55（9）:625⁃632. doi: 10.1111/ j.1348⁃0421.2011.00364.x.<br /> |
| ［9］ | Chng KR, Tay AS, Li C, et al. Whole metagenome profiling reveals skin microbiome⁃dependent susceptibility to atopic dermatitis flare［J］. Nat Microbiol, 2016,1（9）:16106. doi: 10.1038/nmicrobiol. 2016.106.<br /> |
| ［10］ | Amagai M, Matsuyoshi N, Wang ZH, et al. Toxin in bullous impetigo and staphylococcal scalded⁃skin syndrome targets desmoglein 1［J］. Nat Med, 2000,6（11）:1275⁃1277. doi: 10.1038/81385.<br /> |
| ［11］ | Williams MR, Nakatsuji T, Sanford JA, et al. Staphylococcus aureus induces increased serine protease activity in keratinocytes［J］. J Invest Dermatol, 2017,137（2）:377⁃384. doi: 10.1016/j.jid.2016.10.008.<br /> |
| ［12］ | Son ED, Kim HJ, Park T, et al. Staphylococcus aureus inhibits terminal differentiation of normal human keratinocytes by stimulating interleukin⁃6 secretion［J］. J Dermatol Sci, 2014,74（1）:64⁃71. doi: 10.1016/j.jdermsci.2013.12.004. <br /> |
| ［13］ | Nakamura Y, Oscherwitz J, Cease KB, et al. Staphylococcus δ⁃toxin induces allergic skin disease by activating mast cells［J］. Nature, 2013,503（7476）:397⁃401. doi: 10.1038/nature12655.<br /> |
| ［14］ | Eisenbeis J, Peisker H, Backes CS, et al. The extracellular adherence protein （Eap） of Staphylococcus aureus acts as a proliferation and migration repressing factor that alters the cell morphology of keratinocytes［J］. Int J Med Microbiol, 2017,307（2）:116⁃125. doi: 10.1016/j.ijmm.2017.01.002.<br /> |
| ［15］ | Spaulding AR, Salgado⁃Pabón W, Kohler PL, et al. Staphylococcal and streptococcal superantigen exotoxins［J］. Clin Microbiol Rev, 2013,26（3）:422⁃447. doi: 10.1128/CMR.00104⁃12.<br /> |
| ［16］ | Nowrouzian FL, Lina G, Hodille E, et al. Superantigens and adhesins of infant gut commensal Staphylococcus aureus strains and association with subsequent development of atopic eczema［J］. Br J Dermatol, 2017,176（2）:439⁃445. doi: 10.1111/bjd.15138.<br /> |
| ［17］ | Niebuhr M, Scharonow H, Gathmann M, et al. Staphylococcal exotoxins are strong inducers of IL⁃22: a potential role in atopic dermatitis［J］. J Allergy Clin Immunol, 2010,126（6）:1176⁃1183. doi: 10.1016/j.jaci.2010.07.041.<br /> |
| ［18］ | Fujita H. The role of IL⁃22 and Th22 cells in human skin diseases［J］. J Dermatol Sci, 2013,72（1）:3⁃8. doi: 10.1016/j.jdermsci.2013. 04.028.<br /> |
| ［19］ | Hradetzky S, Werfel T, Rösner LM. Autoallergy in atopic dermatitis［J］. Allergo J Int, 2015,24（1）:16⁃22. doi: 10.1007/s40629⁃015⁃0037⁃5.<br /> |
| ［20］ | Biedermann T, Skabytska Y, Kaesler S, et al. Regulation of T cell immunity in atopic dermatitis by microbes: the yin and yang of cutaneous inflammation［J］. Front Immunol, 2015,6:353. doi: 10.3389/fimmu.2015.00353.<br /> |
| ［21］ | Hanzelmann D, Joo HS, Franz⁃Wachtel M, et al. Toll⁃like receptor 2 activation depends on lipopeptide shedding by bacterial surfac⁃tants［J］. Nat Commun, 2016,7:12304. doi: 10.1038/ncomms12304.<br /> |
| ［22］ | Jun SH, Lee JH, Kim SI, et al. Staphylococcus aureus⁃derived membrane vesicles exacerbate skin inflammation in atopic dermatitis［J］. Clin Exp Allergy, 2017,47（1）:85⁃96. doi: 10.1111/cea.12851.<br /> |
| ［23］ | Nakatsuji T, Chen TH, Two AM, et al. Staphylococcus aureus exploits epidermal barrier defects in atopic dermatitis to trigger cytokine ［J］. J Invest Dermatol, 2016,136（11）:2192⁃2200. doi: 10.1016/j.jid.2016.05.127.<br /> |
| ［24］ | Travers JB. Toxic interaction between Th2 cytokines and Staphylococcus aureus in atopic dermatitis［J］. J Invest Dermatol, 2014,134（8）:2069⁃2071. doi: 10.1038/jid.2014.122.<br /> |
| ［25］ | Koymans KJ, Feitsma LJ, Brondijk TH, et al. Structural basis for inhibition of TLR2 by staphylococcal superantigen⁃like protein 3 （SSL3）［J］. Proc Natl Acad Sci U S A, 2015,112（35）:11018⁃11023. doi: 10.1073/pnas.1502026112. <br /> |
| ［26］ | Askarian F, van Sorge NM, Sangvik M, et al. A Staphylococcus aureus TIR domain protein virulence factor blocks TLR2⁃mediated NF⁃κB signaling［J］. J Innate Immun, 2014,6（4）:485⁃498. doi: 10.1159/000357618.<br /> |
| ［27］ | Myles IA, Williams KW, Reckhow JD, et al. Transplantation of human skin microbiota in models of atopic dermatitis［J］. JCI Insight, 2016,1（10）: e86955. doi: 10.1172/jci.insight.86955.<br /> |
| ［28］ | Naik S, Bouladoux N, Wilhelm C, et al. Compartmentalized control of skin immunity by resident commensals［J］. Science, 2012,337（6098）:1115⁃1119. doi: 10.1126/science.1225152.<br /> |
| ［29］ | Lai Y, Di Nardo A, Nakatsuji T, et al. Commensal bacteria regulate Toll⁃like receptor 3⁃dependent inflammation after skin injury［J］. Nat Med, 2009,15（12）:1377⁃1382. doi: 10.1038/nm. 2062.<br /> |
| ［30］ | Volz T, Skabytska Y, Guenova E, et al. Nonpathogenic bacteria alleviating atopic dermatitis inflammation induce IL⁃10⁃producing dendritic cells and regulatory Tr1 cells［J］. J Invest Dermatol, 2014,134（1）:96⁃104. doi: 10.1038/jid.2013.291.<br /> |
| ［31］ | Guéniche A, Bastien P, Ovigne JM, et al. Bifidobacterium longum lysate, a new ingredient for reactive skin［J］. Exp Dermatol, 2010,19（8）:e1⁃8. doi: 10.1111/j.1600⁃0625.2009.00932.x.<br /> |
| ［32］ | Lopes EG, Moreira DA, Gullón P, et al. Topical application of probiotics in skin: adhesion, antimicrobial and antibiofilm in vitro assays［J］. J Appl Microbiol, 2017,122（2）:450⁃461. doi: 10.1111/jam.13349.<br /> |
| ［33］ | Seité S, Zelenkova H, Martin R. Clinical efficacy of emollients in atopic dermatitis patients ⁃ relationship with the skin microbiota modification［J］. Clin Cosmet Investig Dermatol, 2017,10（1）:25⁃33. doi: 10.2147/CCID.S121910.<br /> |
| ［34］ | Park SB, Im M, Lee Y, et al. Effect of emollients containing vegetable⁃derived lactobacillus in the treatment of atopic dermatitis symptoms: split⁃body clinical trial［J］. Ann Dermatol, 2014,26（2）:150⁃155. doi: 10.5021/ad.2014.26.2.150.<br /> |
| ［35］ | Nakatsuji T, Chen TH, Narala S, et al. Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis［J］. Sci Transl Med, 2017,9（378）: eaah4680. doi: 10.1126/scitranslmed.aah4680.<br /> |
| [1] | 宋志强 葛兰. 敏感性皮肤再认识[J]. 中华皮肤科杂志, 2018, 51(7): 548-551. |
| [2] | 王上上 李巍. 特应性皮炎伴播散性传染性软疣一例[J]. 中华皮肤科杂志, 2018, 51(1): 63-63. |
| [3] | 徐松 陈旭 顾恒. 1%吡美莫司乳膏治疗婴幼儿特应性皮炎的安全性及有效性研究进展[J]. 中华皮肤科杂志, 2017, 50(4): 308-310. |
| [4] | 唐苏为 谢韶琼 宋勋 汪青良 沈芳. 迟发型特应性皮炎的研究进展[J]. 中华皮肤科杂志, 2016, 49(6): 444-447. |
| [5] | 邢晓婧 郝飞. 乙醇脂质体局部给药系统的研究进展[J]. 中华皮肤科杂志, 2011, 44(9): 681-683. |
| [6] | 曾美 高谦 何定阳 陈丽华 吴国珍. 特应性皮炎患者外周血CD4+CD25+调节性T细胞的检测[J]. 中华皮肤科杂志, 2010, 43(9): 610-613. |
| [7] | 张丽 狄正鸿 马蕾 陈洪铎 高兴华. 卡介菌多糖核酸对特应性皮炎患者外周血T淋巴细胞表达细胞因子的影响[J]. 中华皮肤科杂志, 2010, 43(8): 583-585. |
| [8] | 郭亚南 文海泉 张桂英 王萍 肖嵘. 卡介菌多糖核酸对二硝基氯苯诱导的Nc/Nga小鼠特应性皮炎样皮损的影响[J]. 中华皮肤科杂志, 2010, 43(7): 497-500. |
| [9] | 杨欢 肖异珠 罗晓燕 欧阳莹 李咏梅 谭琦 向娟 王华. 特应性斑贴试验在诊断特应性皮炎患儿鸡蛋、牛奶过敏中的价值[J]. 中华皮肤科杂志, 2010, 43(6): 378-381. |
| [10] | 路雪艳 李邻峰 王文慧 曹源 刘广仁. 曲安奈德益康唑乳膏长疗程间歇疗法治疗局限性慢性湿疹[J]. 中华皮肤科杂志, 2010, 43(6): 390-392. |
| [11] | 陈洁 石梅 郭一峰 姚志荣. μ-阿片系统在特应性皮炎表皮中的表达及作用初探[J]. 中华皮肤科杂志, 2010, 43(10): 709-712. |
| [12] | 史永俭,张春敏,马冬梅,张春红,魏国,孟丽亚,刘瑛,. 窄谱中波紫外线治疗特应性皮炎及其细胞因子水平检测[J]. 中华皮肤科杂志, 2009, 42(1): 53-54. |
| [13] | 向娟,王华,肖异珠,. 儿童特应性皮炎患者外周血单一核细胞IL-31与疾病严重程度相关性分析[J]. 中华皮肤科杂志, 2008, 41(7): 443-. |
| [14] | 罗晓燕,蒋利萍,刘玮,. 儿童特应性皮炎IL-18基因启动子多态性与相关性研究[J]. 中华皮肤科杂志, 2008, 41(7): 447-. |
| [15] | 孙晓东,闫志华,施辛. 外用吡美莫司治疗特应性皮炎的系统评价[J]. 中华皮肤科杂志, 2008, 41(6): 419-. |
|
